Page 551 - Enfeksiyon Hastalıkları Kitabı
P. 551

Kaynaklar  531


           Calvet HM, Yoshikawa TT: Infections in diabetes. Infect Dis   Clemens J, Shin S, Sur D, Nair GB, Holmgren J. New-generation
              Clin North Am 2001;15(2):407-421.                vaccines against cholera. Nature Rew Gastroenterol Hepatol
                                                               2011;8:701-710.
           Camacho AI, Irache JM, Gamazo C. Recent progress towards
              development of a  Shigella vaccine. Expert Rev Vaccines   Clinical approach to initial choice of antimicrobial therapy, Foot

              2013; 12: 43-55.                                 infection. In: The Sanford guide to antimic robial therapy (Eds;
                                                               Gilbert DN, Moellring RC, Eliopoulus GM, Chambers HF,
           Campylobacter jejuni and related species. Mandell, Duglas, and   Saag MS). 42nd edition. Antimicrobial Therapy, VA; 2012.

              Bennet’s Principles and Practice of Infectious Diseases, Se-
              venth Edition, Mandell GL, Bennet JE, Dolin R (eds), Churc-  Clinical Infectious Disease (Ed; David Schlossberg). 1st Edition,
              hill Livingstone, Philadelphia, 2010, p. 2793-2798.  Cambridge University Pres, 2008.
           Carapetis JR, McDonald M, Wilse NJ. Acut rheumatis fever.   Clotet B, Bellos N, Molina JM, et al. Sande’s HIV/AIDS Medici-
              Lancet 2005;366:155-165.                         ne Global Care. (Eds; Vol berding P. A. , Greene W. C. , Lange
                                                               J. M. A. , Gallant J. E. , Sewankambo N. (eds). 1st edition.
           Carek PJ, Dickerson LM and Sack JL. Diagnosis and manage-  Elsevier Saunders, China;2012.
              ment of osteomyelitis. Am family Physician 2001; 63:2413-  Coffey S, Volberding PA. Overview of antiviral therapy. In:

              2421.
                                                               Sande’s HIV/AIDS Medicine Global Care. (Eds; Vol berding
           Carhan A, Uyar Y, Ozkaya E, Ertek M, et al. Characterization of   P. A., Greene W. C. , Lange J. M. A. , Gallant J. E. , Sewan-

              a sandfly fever Sicilian virus isolated during a sandfl y fever   kambo N. (eds). 1st edition. Elsevier Saunders, China; 2012.
              epidemic in Turkey. J Clin Virol. 2010;48(4):264-9.
                                                            Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 17:
           Cataldo MA, Petrosillo N, Cipriani M, Cauda R, Tacconelli E.   481-92.
              Prosthetic joint infection: recent developments in diagnosis   Conn’s Current Therapy 2012 (Eds: Edward T. Bope and Rick D.

              and management. J Infect 2010;61:443-448.        Kellerman.), 1st Edition, Elsevier Saunders; 2012.
           CDC. Updated recommendations for use of tetanus toxoid,   Cornely OA, Maertens J, Bresnik M, et al: Liposomal ampho-
              reduced diphtheria toxoid and acellular pertussis (Tdap)   tericin B as initial therapy for invasive mold infection: a
              vaccine from the Advisory Committee on Immunization   randomized trial comparing a high-loading dose regimen
              Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011 Jan   with standard dosing (AmBiLoad trial). Clin Infect Dis 2007;
              14;60(1):13-15.                                  44:1289-1297.
           Centers for Disease Control (CDC). Leishmaniasis (online).   Cottagnoud P. Daptomycin: a new treatment for insidious in-
              CDC; Avaliable at: http://www. dpd.cdc.gov/dpdx/HTML/  fections due to gram-positive pathogens. Swiss Med Wkly.
              Leishmaniasis.htm). Accessed 9 Jan 2013.         2008;138:93-99.

           Centers for Disease Control and Prevention. Infl uenza, pneu-  Craig WA, Gudmundsson S. Post-antibiotic effect. In: Antibi-
              mococcal and tetanus toxoid vaccination of adutls — United   otics in laboratory medicine (Eds; Lorian V).  4th edition.
              States, 1993-1997. MMWR Morb Mortal Wkly Rep 2000;   Willi ams and Wilkins, Baltimore; 1996.
              49(SS-9):39.
                                                            Craig WA. Pharmacokinetic/pharmacodynamic parameters:
           Centers for Disease Control and Prevention. Workowski  KA,   Rationale for antibacterial dosing of mice and men. Clin In-
              Berman S: Sexually transmitted diseases treatment guideli-  fect Dis 1998;26:1–12.
              nes,  2010. MMWR 2010;59(RR12);1-110          Cunha BA. Fever of unknown origin: focused diagnostic app-
                                                               roach based on clinical clues from the history, physical
           Centers for Disease Control and Prevention: Update to CDC’s
              sexually transmitted diseases treatment guidelines, 2006:   examination, and laboratory tests. Infect Dis Clin N Am
              fluoroquinolones no longer recommended for treatment of   2007;21:1137-1187.

              gonococcal infections. MMWR  2007; 56:332-336.   Cunha BA. Infectious Mononucleosis. eMedicine.com. 19 Ekim
                                                               2009. http://emedicine.medscape.com/article/ 222040-over-
           Cetti RJ, Venn S, Woodhouse CRJ. The risks of long-term nit-  view

              rofurantoin prophylaxis in patients with recurrent urinary
              tract infection: A recent medico-legal case. BJU Int 2008;   Cunha BA. Legionnaires’ disease: clinical diff erentiation  from
              103: 567-570.                                    typical and other atypical pneumonias. Infect Dis Clin North
                                                               Am. 2010;24(1):73-105.
           Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, et
              al. Viral load as a predictor of outcome in Crimean-Congo   Cunha BA. Septic arthritis  http://emedicine.medscape.com/
              hemorrhagic fever. Clin Infect Dis. 2007 Oct 1;45(7): 96-100.   article/236299-overview erişim tarihi 29.06.2012

           Cevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A,   Cunha BA. The atypical pneumonias: clinical diagnosis and im-
              Akinci E. Clinical and laboratory features of Crimean-Con-  portance Clin Microbiol Infect. 2006;3.12-24.
              go hemorrhagic fever: predictors of fatality. Int J Infect Dis.   Çelebi G, Sözen M. Türkiye’de Hantavirüs enfeksiyonları. Flora
              2008 Jul;12(4):374-379.                          2009; 14 (4): 145-52.
           Choi MH, Hong DG, Seong WJ, et al: Pelvic actinomycosis con-  Çelebi G. Hantavirüs İnfeksiyonları. Klimik Dergisi 2011; 24(3):

              firmed after surgery: single center experience. Arch Gynecol   139-49.
              Obstet 2010; 281:651-656.
                                                            Çelik İ. Ateşli Hastanın Değerlendirilmesi. ANKEM Derg,
           Cholerae: Rehydration terapy. CDC Home. 15 Ekim 2012. http://  2004;18(Ek2):128-132.
              www.cdc.gov/cholera/treatment/rehydration-therapy.html
                                                            Dal T, Dal MS. Bir yıllık sürede dışkı örneklerinde ELISA ile En-
           Cilliers AM. Rheumatic fever and its management. BMJ   tamoeba histolytica Araştırılması. Klinik ve Deneysel Aras-
              2006;333:1153-1156.                              tırmalar Dergisi 2011; 2 (1): 50-54.
   546   547   548   549   550   551   552   553   554   555   556